Geoffrey Dye
Foot Surgery · Pell City, ALNPI 1609146273
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $576 and has fallen 82.5% since, to $101 in 2025.
Across 73 payments — averaging $24.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$231
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$225
- Amgen$220
- Organogenesis Inc.$203
- AbbVie$183
- Solventum Corporation$149
- plus $551 from 17 others
What the payments were for
- Food & beverage$1,760100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 7 | $231 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $225 |
| Amgen | 10 | $220 |
| Organogenesis Inc. | 7 | $203 |
| AbbVie | 5 | $183 |
| Solventum Corporation | 4 | $149 |
| Medela LLC | 1 | $120 |
| Paratek Pharmaceuticals, Inc. | 4 | $61 |
| Smith+Nephew | 3 | $52 |
| Melinta Therapeutics, LLC | 3 | $44 |
| Triad Life Sciences Inc. | 1 | $43 |
| Merck | 3 | $39 |
| Zyla Life Sciences, Inc. | 2 | $23 |
| Convatec Inc. | 1 | $22 |
| Mimedx Group, Inc. | 1 | $22 |
| GRT US Holding, Inc. | 1 | $21 |
| Urgo Medical North America, LLC | 1 | $20 |
| Stryker | 1 | $19 |
| Bioventus LLC | 1 | $17 |
| Osiris Therapeutics Inc. | 1 | $13 |
| DJO, LLC | 1 | $13 |
| Metric Medical Devices, Inc. | 1 | $12 |
| Kerecis Limited | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$125
- Dermagraft$125
- Puraply/Affinity/NuTech$125
- DALVANCE$125
- Invia Motion Endure$120
How this compares
$1,760 in reported general payments places this provider in the 65th percentile of 35 foot surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levofloxacin | 24 | $339 |
| Doxycycline Hyclate | 20 | $308 |
| Gabapentin | 14 | $65 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Pell City
- Brooke GorhamGadsden$211K
- Eric FillingerCullman$19K
- John VanoreGadsden$17K
- Jean PrattGadsden$8K
- Robert RussellBirmingham$7K
- Richard HarrisBirmingham$6K
- James BowmanSylacauga$4K
- Robson AraujoAlbertville$3K
- Stefan ZweigDothan$2K
- Michael McCollumMontgomery$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.